Doxycycline as a potential partner of COVID-19 therapies

Doxycycline as a potential partner of COVID-19 therapies

Coronavirus disease 2019 (COVID-19) is a major public health challenge, and the current antiviral arsenal for treatment is limited, with questionable efficacy. Major efforts are under way for discovery of new effective agents, but the validation of new potential treatments for COVID-19 may take a lo...

Full description

Bibliographic Details
Main Authors: Alexandre E. Malek, Bruno P. Granwehr, Dimitrios P. Kontoyiannis
Format: Article
Language:English
Published: Elsevier 2020-01-01
Series:IDCases
Subjects:
COVID-19
Hydroxychloroquine
Doxycycline
2019 novel coronavirus
Remdesivir
Online Access:http://www.sciencedirect.com/science/article/pii/S2214250920301724

Similar Items

Similar Items